The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Helicobacter pylori Activates Mitogen-activated Protein Kinase Cascades and Induces Expression of the Proto-oncogenes c-fos and c-jun
Open accessAbstract
Helicobacter pylori is an etiological agent in the development of mucosa-associated lymphoid tissue lymphoma and gastric adenocarcinoma. Patients infected with H. pylori carry a 3-6-fold increased risk of developing cancer compared with uninfected individuals. H. pylori strains expressing the cytotoxin-associated antigen A (CagA) are more frequently associated with the development of neoplasia than cagA-negative strains. However, the molecular mechanism by which H. pylori causes neoplastic transformation remains unclear. Here we report that exposure of gastric epithelial cells to H. pylori induces activation of the transcription factor activator protein 1. Activation of the proto-oncogenes c-fos and c-jun is strongly induced. We show that H. pylori activates the ERK/MAP kinase cascade, resulting in Elk-1 phosphorylation and increased c-fos transcription. H. pylori strains that do not express CagA or that are mutated in cag genes encoded by the CagI pathogenicity island do not induce activator protein 1, MAP kinase activity, or c-fos or c-jun activation. Proto-oncogene activation may represent a crucial step in the pathomechanism of H. pylori induced neoplasia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Whitmarsh, A. J., & Davis, R. J. (1996) · Journal of Molecular Medicine · doi:10.1007/s001090050063 · Cited by 1,543
Cellular Transformation and Malignancy Induced by ras Require c-jun
Johnson, R., Spiegelman, B., Hanahan, D., & Wisdom, R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4504 · Cited by 282
Cited by
Helicobacter pylori and gastrointestinal tract adenocarcinomas
Peek, R. M., & Blaser, M. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc703 · Cited by 1,813
Helicobacter pylori: gastric cancer and beyond
Polk, D. B., & Peek, R. M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2857 · Cited by 1,158
“Although the induction of inflammatory cytokines is dependent on the host signalling molecules nuclear factor-κB (NF-κB) and MAP”
BackgroundHelicobacter pylori persistence: biology and disease
Blaser, M. J., & Atherton, J. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420925 · Cited by 948
Chang, F., Steelman, L. S., Lee, J. T., Shelton, J. G., Navolanic, P. M., Blalock, W. L., Franklin, R. A., & McCubrey, J. A. (2003) · Leukemia · doi:10.1038/sj.leu.2402945 · Cited by 725
The Fos family of transcription factors and their role in tumourigenesis
Milde-Langosch, K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.008 · Cited by 583
THE PATHOGENESIS OF HELICOBACTER PYLORI–INDUCED GASTRO-DUODENAL DISEASES
Atherton, J. C. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100125 · Cited by 567
Helicobacter infection and gastric neoplasia
Peek, R. M., & Crabtree, J. E. (2006) · The Journal of Pathology · doi:10.1002/path.1868 · Cited by 550
Smith, M. F., Mitchell, A., Li, G., Ding, S., Fitzmaurice, A. M., Ryan, K., Crowe, S., & Goldberg, J. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305536200 · Cited by 424
Gastric cancer—molecular and clinical dimensions
Wadhwa, R., Song, S., Lee, J.-S., Yao, Y., Wei, Q., & Ajani, J. A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.170 · Cited by 423
Grb2 Is a Key Mediator of Helicobacter pylori CagA Protein Activities
Mimuro, H., Suzuki, T., Tanaka, J., Asahi, M., Haas, R., & Sasakawa, C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00681-0 · Cited by 370
Oxindole: A chemical prism carrying plethora of therapeutic benefits
Kaur, M., Singh, M., Chadha, N., & Silakari, O. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.011 · Cited by 349
Helicobacter pylori Flagellin Evades Toll‐Like Receptor 5–Mediated Innate Immunity
Gewirtz, A. T., Yu, Y., Krishna, U. S., Israel, D. A., Lyons, S. L., & Peek, Jr. (2004) · The Journal of Infectious Diseases · doi:10.1086/386289 · Cited by 293
Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells
Bagnoli, F., Buti, L., Tompkins, L., Covacci, A., & Amieva, M. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502598102 · Cited by 266
Self-citationRole of type IV secretion in Helicobacter pylori pathogenesis
Backert, S., & Selbach, M. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01156.x · Cited by 255
Evodiamine Inhibits Helicobacter pylori Growth and Helicobacter pylori-Induced Inflammation
Yang, J. Y., Kim, J.-B., Lee, P., & Kim, S.-H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073385 · Cited by 54
“pylori infection in gastric epithelial cells [61].”
Akcelik-Deveci, S., Kılıç, E., Mansur-Ozen, N., Timucin, E., Buyukcolak, Y., & Oktem-Okullu, S. (2024) · PLOS ONE · doi:10.1371/journal.pone.0300557 · Cited by 2
Metadata
- Authors
- Meyer-ter-Vehn, T., Covacci, A., Kist, M., & Pahl, H. L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-05
- Volume
- 275
- Issue
- 21
- Pages
- 16064-16072
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2147025591
- Cited by
- 249
- References
- 3
- FWCI
- 17.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.